País: Jordania
Idioma: inglés
Fuente: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)
Fluoxetine 20 mg
شركة مستودع الادوية العربي - THE ARAB DRUG STORE P.S.C
N06AB03
Fluoxetine 20 mg
20 mg
28
PATHEON/FRANCE (فرنسا)
7.23 :سعر الجمهور + الضريبة
sens lecture code laetus PLI RECTO VERSO __ __ dÉFIleMent recto 1 COULEUR(S) PANTONE DANS L’ORDRE PRÉVU D’IMPRESSION: code artIcle MU3071_NOT descrIPtIF tecHnIQue de l’artIcle (Issu 7065741) NOTICE TRIPLE PLIÉE (l05) PROZAC 20 MG / GÉLULES / EXPORT V2_14 Jun 2016 laIZe 170 MM NOIR du noIr TRAMES: LINÉATURE: 150 LPI INCLINAISON : taille mini du texte : 7,5 PT tableau : 6,5 Plan de dÉrouleMent n° 14 code laetus : 276 dIMensIons : 250 X 170 MM dÉPlIÉe : 250 X 510 MM responsable: M r Franc Pascal PATHEON France 40, boulevard de Champaret CS 11006 – 38307 Bourgoin-Jallieu Cedex tél.: 04 74 93 88 37 fax.: 04 74 93 87 81 RECTO / VERSO EN ROULEAU / P. 1 1 eusPc03Mar2016 PROZAC FLUOXETINE HYDROCHLORIDE 1. NAME OF THE MEDICINAL PRODUCT Prozac* 20 mg hard capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION each capsule contains 20 mg of fluoxetine (as fluoxetine hydrochloride). For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Hard capsules. the capsules are green and yellow, printed ‘lilly 3105’ . 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS ADULTS: Major depressive episodes. obsessive-compulsive disorder. Bulimia nervosa: Prozac is indicated as a complement of psychotherapy for the reduction of binge-eating and purging activity. CHILDREN AND ADOLESCENTS AGED 8 YEARS AND ABOVE: Moderate to severe major depressive episode, if depression is unresponsive to psychological therapy after 4–6 sessions. antidepressant medication should be offered to a child or young person with moderate to severe depression only in combination with a concurrent psychological therapy. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults_ _Major depressive episodes_ adults and the elderly: the recommended dose is 20 mg daily. dosage should be reviewed and adjusted if necessary within 3 to 4 weeks of initiation of therapy and thereafter as judged clinically appropriate. although there may be an increased potential for undesirable effects at higher doses, in some patients, with insufficien Leer el documento completo